Nephros INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
NEPH
Nephros INCSCHEDULE: Wexford Capital Reduces Nephros Stake
Wexford Capital LP and associated entities have amended their Schedule 13D filing, reporting a decrease in their beneficial ownership of Nephros, Inc. common stock to 2.06%.